Getinge traded at 239.60 this Tuesday September 8th, decreasing 4.00 or 1.64 percent since the previous trading session. Looking back, over the last four weeks, Getinge lost 0.17 percent. Over the last 12 months, its price rose by 12.86 percent. Looking ahead, we forecast Getinge to be priced at 235.88 by the end of this quarter and at 218.96 in one year, according to Trading Economics global macro models projections and analysts expectations.
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.